Transforming growth factor β1(TGF-β1) is transferred to NK cells via exosomes generated from hypoxic tumor cells, which decrease NK cell activity, leading to desensitization and inhibition of NKG2D receptors in lung cancer [101, 103]. This evidence concerns the gene TGFB1 and lung cancer.